142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

301294
Beyond HIV/AIDS: Ameliorating Chronic Disease Stigma in U.S. Public Health Law

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Wednesday, November 19, 2014 : 10:50 AM - 11:10 AM

Daniel Goldberg, J.D., Ph.D , Department of Bioethics & Interdisciplinary Studies, The Brody School of Medicine, East Carolina University, Greenville, NC
The central claim of this paper is that understanding how U.S. public health law fuels chronic disease stigma is crucial to ameliorating its inequitable burden.  Stigma is a travesty both because it is independently correlated with adverse health and because it is intolerable in a just social order.  Fortunately, there is increasing recognition that disease stigma is an important determinant of population health and that law is a principal pathway through which such stigma flows.  However, the vast majority of legal and policy analyses of disease stigma have emphasized sexually-transmitted disease and HIV/AIDS in particular.  Yet, significant evidence suggests that chronic disease stigma is both widespread and is mediated by public health laws.  Drawing on Burris’s influential taxonomy of disease stigma and public health law (2002), the present paper – targeted at an expert audience – argues that chronic disease stigma in the U.S. is hegemonic, which means that it is more likely to be accepted as natural and even to be invisible since it so tightly reflects dominant social norms.  The paper evaluates how a variety of laws and policies reflect, sustain and fuel stigma in two specific disease paradigms – chronic pain and type II diabetes – and applies Powers and Faden’s health sufficiency model of social justice to show that such stigma and its inequitable distribution is ethically unacceptable.  The paper concludes by offering recommendations regarding evidence-based anti-stigma mechanisms in public health law and policy that could alleviate pain and type II diabetes stigma respectively.

Learning Areas:

Ethics, professional and legal requirements
Public health or related public policy

Learning Objectives:
Describe how U.S. public health laws reflect and fuel chronic disease stigma in paradigms of pain and type II diabetes; Explain why chronic disease stigma qualifies as hegemonic; and Identify three anti-stigma legal/policy mechanisms that may ameliorate chronic disease stigma.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am an attorney and public health law scholar and have produced multiple peer-reviewed publications and refereed presentations on a variety of public health law & policy topics. I have been studying and publishing on disease stigma and the law for the last 3-4 years, and have written, spoken, and taught on the subject on a number of occasions.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.